RGC logo

Regencell Bioscience Holdings Limited Stock Price

NasdaqCM:RGC Community·US$6.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 10 Fair Values set on narratives written by author

RGC Share Price Performance

US$12.48
12.32 (7,931.20%)
US$12.48
12.32 (7,931.20%)
Price US$12.48

RGC Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with low risk.

3 Risks
0 Rewards

Regencell Bioscience Holdings Limited Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$3.6m

Other Expenses

-US$3.6m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.0072
0%
0%
0%
View Full Analysis

About RGC

Founded
2014
Employees
10
CEO
Yat-Gai Au
WebsiteView website
www.regencellbioscience.com

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Recent RGC News & Updates

Recent updates

No updates